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Abstract 
The food industry has been struggling with existing guidance on how to prepare health claim dossiers. Hence 
the EU-funded project PATHWAY-27 seeks to provide a more tailored guidance.  
Within this project, robust guidelines for the food industry will be developed. The guidelines will be applicable 
to bioactives and bioactive enriched foods in general, to facilitate health claim documentation and dossiers. 
Based on a questionnaire, information on the needs and difficulties of the food industry in reaching the 
requirements established by the national and EU authorities (EFSA) was gathered. Particular emphasis was 
placed on scientific, economic, technical and technological barriers.  
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1. Introduction 
Interest in healthy eating and living is growing, and the food sector has been trying to satisfy related interests 
and needs. However, there are still many gaps in the available knowledge of the food sector on how to 
accomplish such a product development. (FoodDrinkEurope, 2011) 
The process of ‘creating’ a health claim is subject to many strict rules (EC No 1924/2006) and the food industry 
must follow a complex and challenging procedure to meet the requirements established by national and EU 
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authorities (i.e. the European Food Safety Authority (EFSA)). Moreover, only a small proportion of the claim 
dossiers submitted to EFSA (mostly vitamins and minerals) were awarded a positive opinion recently. 
(European Commission, EU Register, 2013; European Commission, 2006) 
Based on the general strategy of the EU-funded project PATHWAY-27 (Pivotal Assessment of The effects of 
bioactives on Health and Wellbeing. From human genoma to food industry), a guidance document will be 
prepared that will inform and assist the food industry sector, especially SMEs, to produce bioactive-enriched 
foods (BEF) with supportive health claims in line with EU legislation. 
As a first step, a questionnaire was developed to collect and identify the needs and difficulties of the 
industry/SMEs in establishing and submitting health and nutrition claims for food products enriched with 
health-promoting bioactives. 
This article presents the results of the survey and aims to give a general overview on the concept of the 
questionnaire.  
 
2. Material and Methods  
A health claim is any statement about a relationship between food and health. The European Commission 
authorises different health claims provided they are based on scientific evidence and can be easily understood 
by consumers. The European Food Safety Authority (EFSA) is responsible for evaluating the scientific evidence 
supporting health claims. The Commission draws up lists of health claims including the different types of 
authorised and rejected health claims in the EU. There are two types of health claims: ‘enhanced function 
claims’ and ‘reduced risk claims’. (European Commission, 2012) Nutrition claim means any claim which states, 
suggests or implies that a food has particular beneficial nutritional properties due to:  
(a) the energy (calorific value) it 
(i) provides; 
(ii) provides at a reduced or increased rate; or 
(iii) does not provide; and/or 
(b) the nutrients or other substances it 
(i) contains; 
(ii) contains in reduced or increased proportions; or 
(iii) does not contain; 
Nutrition claims are only permitted if they are listed in the Annex of Regulation (EC) No 1924/2006. (European 
Commission, Food Safety, 2013) 
For the purpose of analysing the needs and difficulties of the food industry/SMEs in establishing and submitting 
health and nutrition claims, a dedicated questionnaire was developed in English and was translated into five 
languages (French, German, Hungarian, Italian and Spanish). The full English version of the questionnaire is 
presented in Annex I. 
The survey focused on the main areas of the PATHWAY-27 project, namely on the implementation of the 
requirements established by national and EU authorities, as well as the European legislation; the needs and 
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difficulties of the industry/SMEs in establishing and submitting health and nutrition claims for food products 
enriched with health-promoting bioactives; and on the innovation potential and competitiveness of SMEs. In 
accordance with the concept of the project, the questionnaire was divided into 3 sections:   
• General information about the respondent company 
• Competitiveness and innovative indicators of the company 
• Better understanding of the companies’ view in terms of product development with health and 
nutrition claims 
Based on the aim of the survey, the following inclusion criteria and sample quotas were applied:  
• Food industry including food manufacturers, food ingredient suppliers, bioactive compounds 
producers and relevant service providers. 
• Balanced 40% from large companies and the other 60% from SMEs.  
• Functional food companies, that have already had product with health and nutrition claim(s) and those 
ones that are planning to develop such products, ideally 50-50%. 
The questionnaire was distributed among food enterprises and other relevant sectors, to estimate the current 
situation within the food industry related to health and nutrition claims. 
Combined methods were applied for data collection in order to increase the response rate. 
1. Online questionnaire 
2. Paper-based questionnaire sent by post or email 
3. Phone interview 
4. Personal interviews 
The questionnaire was completed anonymously and all responses were treated as strictly confidential.  
The questionnaire was sent out to 2594 companies from which 167 responses were collected from 17 countries 
(Austria, Belgium, Denmark, Finland, France, Germany, Greece, Hungary, India, Italy, Portugal, Romania Spain, 
Sweden, Turkey and United Kingdom and USA) by the 25 project partners broadly distributed in Europe and by 
companies not participating in the project through the international business networks of the project partners.  
After the first data check, 42 questionnaires were excluded due to invalid and unusable answers. Therefore, 
125 questionnaires were assessed as valid (fully completed). 
 
3. Results and Discussion 
Sample characteristics 
In order to achieve the most appropriate responses, flexibility was allowed and minor deviations were accepted 
in the predefined inclusion criteria. 
The survey focused on the highlighted food sectors, considering the main areas of the PATHWAY-27 project. 
Respondents were coming from the following areas:  
• red and white meat, poultry and meat products 
• fish and fish products 
• egg and egg products* 
• dairy products* 
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• processed fruit and vegetables 
• grain products, cereals, industrial bakery and pastry, confectionary, snacks* 
• combined products 
• beverages 
• oils and fats 
• dry goods, other ingredients and supplements 
• other 
*relevant food areas for PATHWAY-27 project 
 
63% of the companies providing sufficient response were food manufacturers, 26% were food ingredient 
suppliers, and 6% were related service providers. Only 5% of the companies represented other types of 
businesses, such as distributor of dietetic products, transformation and characterisation of plastics, consultant, 
fast food supplier, crop protection products and seed manufacturer and test kit supplier (Figure 1.). 
 
Figure 1: Type of the companies 
 
Figure 2. shows the distribution (%) of the department or function of the respondents. Most of the respondents 
were from the research and development area, and a considerable number (19%) of the respondents were 
from quality control and management departments.  
 
63% 
26% 
6% 
5% 
Food manufacturer 
Food ingredient supplier 
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Figure 2: Department/function of the respondents 
 
The size of the companies is shown in Figure 3. 44% of the respondents were large companies and 56% of them 
were SMEs. This distribution is close to the filtered criteria (balanced 40% from large companies and the other 
60% from SMEs).  
 
 
Figure 3: Size of the companies  
  
Table 1: Definition of an SME (European Commission, 2014) 
Company category  Employees  Turnover  or Balance sheet total  
Medium-sized < 250 ≤ € 50 m ≤ € 43 m 
Small < 50 ≤ € 10 m ≤ € 10 m 
15% 
5% 
6% 
19% 
47% 
3% 
5% Management 
Marketing/Market research 
Production 
Quality control 
R&D 
Purchasing 
Other 
44% 
56% 
Large enterprises 
SMEs 
18.55% - medium 
22.58% - small 
15.32% - micro 
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Micro < 10 ≤ € 2 m ≤ € 2 m 
 
Breakdown by product scope, at the medium or large sized companies are shown in the following list. 
Distribution of the product scope of the large companies by the number of the respondents: 
• Grain products, cereals, industrial bakery and pastry, confectionary, snacks (17) 
• Dairy products (14) 
• Dry goods, other ingredients and supplements (12) 
• Beverages (7) 
• Oils and fats (6) 
• Red and white meat, poultry and meat products (5) 
• Combined products (5) 
• Processed fruit and vegetables (4) 
• Fish and fish products (1) 
• Egg and egg products (1) 
• Other (5) 
 
Breakdown by product scope of the small and medium sized companies by the number of the respondents: 
• Grain products, cereals, industrial bakery and pastry, confectionary, snacks (22) 
• Dry goods, other ingredients and supplements (16) 
• Processed fruit and vegetables (13) 
• Oils and fats (11) 
• Dairy products (11) 
• Beverages (10) 
• Red and white meat, poultry and meat products (7) 
• Combined products (7) 
• Egg and egg products (6) 
• Fish and fish products (5) 
• Other (6) 
Competitiveness and innovation indicators 
In “Competitiveness and innovation indicators” section of the questionnaire, indicators for measuring 
innovation and competiveness were elicited.   
36% of the respondents were of the opinion that the use of health and nutrition claims has strong (strong, very 
strong or extremely strong) contribution to the success of a company. (Figure 4.) 
Hegyi et al. 
7 
 
 
Figure 4: Perceived contribution of health and nutrition claims to the success of the company 
 
The most important factor highlighted as contributing to the success of the company in the market was the 
profit, followed by factors related to good sales performance. Surprisingly, the third important ‘category’ was 
in relation to marketing, consumers’ satisfaction and loyalty. The number of new customers achieved in the 
domestic market was significantly more important than the number of new customers achieved in the export 
market. According to the answers, it seems that market share and revenue were more important to large 
companies than to SMEs. 
 
Use of health and nutrition claims 
Figure 5. shows the distribution (%) of the respondents related to the use of health and nutrition claims on 
their products. 61% of the respondents use or plan to use health claims, while 39% did not produce products 
with health claims or with nutrition claims, nor were they planning to use health or nutrition claims on their 
products.  
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Figure 5: Using health claims on products 
 
Information about the companies which do not use health or nutrition claims on their products and do not 
plan to use claims 
Figure 6. shows that the main reasons for not using health claims were: i) lack of adequate resources/facilities, 
ii) insufficient return on investment expected, iii) lack of financial resources. 25% of the companies stated not 
to have enough experience in health claim substantiation, so they deemed the development process too risky. 
Less than 10 respondents listed the following comments as a reason: 
• they are not interested, 
• they do not have qualified people for the related analyses, 
• they do not trust in the feasibility of such project’s results, 
• they set up health claim submission process in the past but it failed. 
 
 
Other difficulties highlighted by the respondents were mainly in connection with the national authorities. The 
lack of positive EFSA opinions has caused insecurity about submitting or re-submitting a dossier. In addition all 
the companies stated that the communication with the national authorities and EFSA was very difficult, hence 
making the submission procedure and the requirements unclear for them. 
61% 
39% Use or plan to use health claims 
Do not use health claims 
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Figure 6: Reasons of why the companies do not use health claims on the products 
 
Information about the companies which use health or nutrition claims on their products or plan to use health 
claims 
27% of the respondents have already submitted health claim dossiers to EFSA (1-20 dossier/s per company), 
but the number of dossiers approved was very low. The most popular products on which the companies used 
or planned to use health claims were cereal products, bakery, confectionary, dairy products and beverages. 
 
0% 5% 10% 15% 20% 25% 30% 35% 40% 
We set up health claim submission process in the 
past but it was a failure 
We do not trust in the feasibility of such project’s 
results 
We do not have qualified persons for the related 
analyses 
We are not interested 
Other reasons 
We do not have enough information/knowledge 
We do not have experience and the development 
is too much risk for us 
We do not have the financial resources to submit a 
health claims dossier 
We do not believe there is an appropriate return 
on investment 
We are aware of the importance of health claims, 
but we do not have adequate resources/facilities … 
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Figure 7: Products on which the companies use or plan to use health claims 
 
More than half of the companies use external support during the health claim substantiation, and some of 
these companies were not familiar with the official guideline (Guidance for applicants on health claims) 
provided by EFSA. The following issues were suggested to be added to the document: 
• Acceptable, representative clinical models of the general population, 
• Valid protocols, valid biomarkers, valid claim formulation, 
• Study design and type of research strategy, 
• Reporting of study results, 
• More specific definition/list of appropriate measurement techniques. 
 
More than 80% of the companies thought that it was difficult to substantiate a health claim (Figure 8.). They 
also needed support with collecting scientific data/information in general, and information about consumers’ 
requirements and behaviour in particular. Furthermore, they preferred the idea of working with a consultancy 
company and guidelines for carrying out tests and studies. 
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Figure 8: Perceived difficulty of the substantiation of a health claim 
 
Barriers during nutrition and health claim substantiation 
The questionnaire measured the influence of scientific, economic, technical and technological barriers during 
health claim substantiation. The following key difficulties were determined by the respondents:  
The lack of markers to be used and accepted by EFSA, difficulties in establishing the relationship between the 
food and the claimed effect, difficulty in setting up experimental design and human intervention studies, and 
the lack of human intervention studies related to bioactive ingredients were found as the most important 
scientific barriers. In terms of the technical/technological barriers, there were no large differences within the 
listed factors:  
• Lack of communication with the national and/or EU authorities; 
• Lack of guidelines/supporting documents; 
• Lack of specialised human resource; 
• Lack of communication within the company; 
• Lack of knowledge (how best to conduct RCT, statistics); 
• Lack of specific technology; 
• Lack of applicable technology; 
• Lack of tools (specific material to evaluated results); 
• Difficulties in food characterisation (e.g. polyphenols). 
 
However, the lack of comprehensive guidelines caused more difficulty than the lack of communication within 
the company. The most important economic barriers were the costs for human intervention studies and the 
2% 5% 
8% 
24% 
20% 
25% 
16% Not difficult 
Not very difficult 
Slightly difficult 
Moderately difficult 
Strongly difficult 
Very difficult 
Extremely difficult 
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health claim dossier, the length of the process of authorisation and uncertainty about the return on 
investment. The lack of connection with the research and development area was not a critical barrier. It 
appears that the communication within companies works fairly smoothly, which might be explained by the 
standardised company product development procedures. 
A factor analysis of the scientific, technical/technological and economic barriers was carried out, from which 
five main factors emerged: 
1. factor: Clinical study, test design 
2. factor: Labelling 
3. factor: Intellectual property rights 
4. factor: Technology 
5. factor: Too much effort in an uncertain business environment 
 
1. factor: Clinical study, test design 
In this group the most important difficulties and barriers were connected to the human intervention studies, 
which is a necessary element of the health claim substantiation. The respondents thought that the following 
barriers most influenced the health claim substantiation: i) difficulties in the setting up of experimental design 
and carrying out human intervention studies; ii) difficulties in establishing the relationship between the 
food/constituent and the claimed effect; iii) lack of existing human intervention studies set-up related to the 
presence of bioactive ingredient; iv) cost of conducting human intervention studies if no relevant data are 
available; v) lack of access to human and clinical study providers; vi) poor access to relevant scientific data; and 
vii) difficulties in finding, extracting, stabilising and integrating the appropriate bioactive ingredient. 
2. factor: Labelling 
The second factor was connected to the labelling of the products, which is a dominant part of using health and 
nutrition claims on foods. The most important barriers were: i) lack of information regarding labelling and ii) 
compliance with labelling legislation. 
3. factor: Intellectual property rights 
Within this factor the most important barriers was related to intellectual property rights. This is a particular 
problem in that after successful substantiation the claim can be used by the competitor companies as well. The 
most influencing barriers were: i) difficulties with intellectual property rights and ii) inappropriate protection 
for use of successful health claims. 
4. factor: Technology 
Regarding technology as a factor, respondents viewed the following barriers as most relevant: i) lack of specific 
technology; ii) lack of applicable technology; and iii) lack of tools (specific material to evaluate results). 
5. factor: Too much effort in an uncertain business environment 
Management of businesses in an uncertain environment causes a high level of insecurity during the product 
development phase. For this reason the following difficulties were identified by the respondents as the most 
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influencing factors: i) return on investment not guaranteed; ii) rising input costs; iii) lack of internal resources; 
iv) unfair commercial practices; and v) length of the process of authorisation. 
 
4. Conclusions  
In the field of industry surveys in general, 5-10% response rate is a common and acceptable rate. In spite of the 
relatively low response rate (6.4%; 4.8% valid), we conclude that the survey successfully reached the target 
audience, because the majority of the respondents were from the proposed target groups (from SMEs category 
and real users) and/or were more or less experienced on product development with health and nutrition 
claims.  The low response rate might be considered as a limitation, but the number of valid questionnaires 
(125) was a sufficient number for carrying out a quantitative evaluation and to identify the hot topics for the 
development of an industry guideline on the development of foods with health claims. 
More than half of the respondents stated that product development with health and nutrition claims was a 
very difficult process due to the scientific, economic, technical and technological barriers discussed in the 
article. However the majority of the respondents saw clear benefits despite the complicated development 
process; more than half of the respondents stated that the development of products with health and nutrition 
claims can contribute to market success. 
Having a well-founded view on the most important scientific, technical/technological and economic barriers, it 
can be stated that industry has to face several difficulties and barriers during the process of the health claim 
substantiation: The lack of markers to be used and accepted by EFSA; the difficulties in establishing the 
relationship between the food and the claimed effect; the difficulty in setting up experimental design and 
human intervention studies; and the lack of human intervention studies related to active substance were found 
as the most important scientific barriers. In terms of the technical and technological barriers there were no 
large differences among the listed factors, but the lack of comprehensive guidelines caused more difficulty than 
the lack of communication within the company. According to the respondents’ opinion, the most important 
economic barriers were the cost of the human intervention studies and the health claim dossier; the length of 
the process of authorization and the fact that the return of investment is not guaranteed. The lack of 
connection with research and development area was not perceived as a critical barrier. To compare this 
statement with the technical one, it seems that internal communication within the surveyed companies works 
fairly smoothly. 
Even though, human studies are likely to remain expensive, and the amount and quality of data required for a 
successful dossier is probably not going to change soon, the necessity of the guidelines intended to be 
developed within the PATHWAY-27 project, got a confirmation, as companies could get a clearer picture on 
what is needed in case they decide to develop products with nutrition or health claims. 
Together with evidence from previous literature and knowledge from the project partners, these results will 
build the basis for the preparation of the PATHWAY-27 guidelines targeted at the food industry. 
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Appendices 
Annex I. QUESTIONNAIRE TO INDUSTRIES 
SECTION 1 – GENERAL INFORMATION ON YOUR COMPANY 
1.1 Type of the Company (Please tick the relevant box!) 
  Food manufacturer 
  Food ingredient supplier (raw material handler, added-value processors/suppliers) 
  Related service provider 
  Other (please specify)___________________ 
 
1.2 Please indicate your department/function in your Company (Please, tick more than one box if applicable!) 
  Management   Marketing/Market research   Production 
  Quality Control   Research & Development   Purchasing 
  Other (please specify)___________________ 
 
1.3 Country where you are personally based: 
___________________________________ 
 
1.4 Total number of employees in your company (in case of more than one manufacturing site, please reply for 
your branch only) (Please tick the relevant box!) 
  More than 1000 employees 
  251 to 1000 employees 
  51 to 250 employees 
  11 to 50 employees 
  10 employees or less 
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1.5 Turnover of your company (million Euros) as sub-divided by the EU* (Please tick the relevant box!) 
  More than 100 m € 
  51 m € to 100 m € 
  11 m € to 50 m € 
  3 m € to 10 m € 
  2 m € or less 
*http://ec.europa.eu/enterprise/policies/sme/facts-figures-analysis/sme-definition/ 
 
Company category  Employees  Turnover  or Balance sheet total  
Medium-sized < 250 ≤ € 50 m ≤ € 43 m 
Small < 50 ≤ € 10 m ≤ € 10 m 
Micro < 10 ≤ € 2 m ≤ € 2 m 
 
1.6 Please indicate the product scope of your company! (Please tick more than one box if applicable!) 
  Red and white meat, poultry and meat products 
  Fish and fish products 
  Egg and egg products 
  Dairy products 
  Processed fruit and vegetables 
  Grain products, cereals, industrial bakery and pastry, confectionary, snacks 
  Combined products 
  Beverages 
  Oils and fats 
  Dry goods, other ingredients and supplements 
  Other (please specify) ____________________ 
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SECTION 2 – COMPETITIVENESS AND INNOVATION INDICATORS 
 
2.1 How much does the development of products with health claims contribute to the success of your company 
in the market? (Please tick the relevant number!)  
No 
contribution 
Very Low 
contribution 
Low 
contribution 
Moderate 
contribution 
Strong 
contribution 
Very strong 
contribution 
Extremely 
strong 
contribution 
1 2 3 4 5 6 7 
 
2.2 How do you measure your success in the market? Please indicate the importance of the following indicators 
in the measurement of success! 
(Please tick the relevant number!) 
Indicators Importance 
 
Not 
important 
Slightly 
less 
important 
Slightly 
important 
Moderately 
important 
Important 
Very 
important 
Extremely 
important 
Number of new 
successful 
prototypes 
produced in lab 
environment 
    1           2           3            4            5            6           7 
Number of 
prototypes that go 
through  factory 
trials successfully 
    1           2           3            4            5            6           7 
Number of products 
launched onto the 
market 
    1           2           3            4            5            6           7 
Reaching new 
market or 
consumer segment 
    1           2           3            4            5            6           7 
Higher and added 
value products for 
the consumers 
    1           2           3            4            5            6           7 
Increasing 
consumer loyalty 
    1           2           3            4            5            6           7 
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Indicators Importance 
 
Not 
important 
Slightly 
less 
important 
Slightly 
important 
Moderately 
important 
Important 
Very 
important 
Extremely 
important 
Number of new 
customers achieved 
in the domestic 
market 
    1           2           3            4            5            6           7 
Market share     1           2           3            4            5            6           7 
Export share     1           2           3            4            5            6           7 
Sales volume     1           2           3            4            5            6           7 
Revenue     1           2           3            4            5            6           7 
Profit     1           2           3            4            5            6           7 
Number of  new 
customers achieved 
in the export market 
    1           2           3            4            5            6           7 
Time after launch  
to reach certain 
sales/market share 
    1           2           3            4            5            6           7 
First launch by food 
manufacturer which 
includes a 
specific/new 
ingredient 
    1           2           3            4            5            6           7 
Please, indicate if 
you consider any 
other indicators: 
 
     1           2           3            4            5            6           7 
     1           2           3            4            5            6           7 
     1           2           3            4            5            6           7 
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SECTION 3 – USE OF NUTRITION AND HEALTH CLAIMS  IN THE COMPANY 
 
3.1 Does your company produce products (including ingredients that qualify for a health claim) with health 
claims? (Please tick the relevant box!) 
  Yes    No 
 
3.2 Does your company produce products (including ingredients) with nutritional claims? (Please tick the 
relevant box!) 
  Yes    No 
  Please specify______________________________ 
 
3.3 Do you plan to use health claims on your product/s (including ingredients)? (Please tick the relevant box!) 
  Yes    No 
 
3.4 Are you interested in using health claims on your product/s (including ingredients)? (Please tick the 
relevant box!) 
  Yes    No 
 
If the answer is “No” in question 3.1, 3.2, 3.3 and 3.4, please go to question 3.16! 
 
3.5 How many health claim dossier(s) did your company submit to EFSA? 
______________ 
 
3.6 How many of these health claim dossier(s) were successfully accepted by EFSA? 
______________ 
 
3.7 What kind of health claims is your company interested in? (Please tick more than one box if applicable!) 
Health claims describing or referring to: 
  the role of a nutrient or other substance in growth, development and the functions of the body /Article 13, 
(a)/; 
  psychological and behavioural functions /Article 13, (b)/; 
  slimming or weight-control or a reduction in the sense of hunger or an increase in the sense of satiety or 
the reduction of the available energy from the diet /Article 13, (c)/; 
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  reduction of disease risk claims /Article 14, (a)/; 
  claims referring to children's development and gut health (Prebiotics and Probiotics) /Article 14, (b)/. 
 
3.8 For what kind of products does your company use or plan to use health claims? (Please tick more than one 
box if applicable!) 
Red and white meat, poultry and meat products, please specify____________________ 
  Fish and fish products, please specify______________________________ 
  Egg and egg products, please specify______________________________ 
  Dairy products, please specify______________________________ 
  Processed fruit and vegetables, please specify______________________________ 
  Grain products, cereals, industrial bakery and pastry, confectionary, snacks, please specify ______ 
  Combined products, please specify______________________________ 
  Beverages, please specify______________________________ 
  Oils and fats, please specify______________________________ 
Dry goods, other ingredients and supplements, please specify______________________________ 
  Other, please specify______________________________ 
 
3.9 Where do you get your information on health claims from?  
(Please tick more than one box if applicable!) 
  Scientific papers/review 
  Professional journals 
  Books 
  Guidelines 
  EFSA/FDA/national agencies web pages 
  Internet 
  Professional e-groups forums 
  Seminars/courses 
  Conferences/workshops 
  Monitoring, benchmarking competitors’ products, companies 
  Other (please specify)  
 
3.10 Do you use any external support during the health claim substantiation? (Please tick the relevant box!) 
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  Yes    No 
If yes, please specify what kind of agency: 
  Consultancy/advisor 
  Research institute 
  University 
  Supplier 
  Food Industry Federation 
  Food Control Authority 
  Customer 
  Other, please specify: ________________________________ 
 
3.11 What do you think about the information provided in the official guideline (Guidance for applicants on 
health claims) provided by EFSA? (Please tick more than one box if applicable!) 
  I do not know the guideline 
  Comprehensive 
  Clear instructions 
  Unclear instructions 
  Not detailed enough  
  Too professional/technical 
  Lack of certain information, (please, specify): ___________________________ 
  Other (please, specify it): ___________________________ 
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3.12 How difficult is it for you to substantiate a product (including ingredients) with health claims? (Please 
tick the relevant number!) 
 
Not difficult 
Not very 
difficult 
Slightly 
difficult 
Moderately 
difficult 
Strongly 
difficult 
Very difficult 
Extremely 
difficult 
1 2 3 4 5 6 7 
 
3.13 How strong is the influence of scientific, economic, technical and technological barriers during health 
claim substantiation? (Please score the difficulties, barriers or put an X if the barriers are not relevant for you!) 
Barriers/difficulties  Influence 
 
Not 
relevan
t 
No 
influenc
e 
Very 
slight 
influenc
e 
Slightly 
Influenc
e 
Moderat
e 
influenc
e 
Strong 
influenc
e 
Very 
strong 
influenc
e 
Extremel
y strong 
influence 
SCIENTIFIC   
Poor access to 
supportive scientific 
data 
 
    1          2           3           4          5           6           7 
Poor quality of the 
data on human 
intervention studies  
 
    1          2           3           4          5           6           7 
Poor quality of the 
data on other studies 
(e.g. animal) 
 
    1          2           3           4          5           6           7 
Lack of existing 
human intervention 
studies set-up 
related to the 
presence of active 
substance 
 
    1          2           3           4          5           6           7 
Difficulties in 
establishing the 
relationship between 
the food/constituent 
and the claimed 
effect 
 
    1          2           3           4          5           6           7 
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Barriers/difficulties  Influence 
 
Not 
relevan
t 
No 
influenc
e 
Very 
slight 
influenc
e 
Slightly 
Influenc
e 
Moderat
e 
influenc
e 
Strong 
influenc
e 
Very 
strong 
influenc
e 
Extremel
y strong 
influence 
Difficulties in finding, 
extracting, stabilising 
and integrating of 
the appropriate 
active substance 
 
    1          2           3           4          5           6           7 
Lack of access for 
human and clinical 
study providers 
 
    1          2           3           4          5           6           7 
Difficulties in the 
setting up 
experimental design 
and carrying out 
human intervention 
studies 
 
    1          2           3           4          5           6           7 
Lack of markers, to 
be used, accepted by 
EFSA 
 
    1          2           3           4          5           6           7 
Lack of information 
regarding labelling 
 
    1          2           3           4          5           6           7 
Compliance to 
legislation of 
labelling 
 
    1          2           3           4          5           6           7 
Ethical problems (to 
conduct human 
studies) 
 
    1          2           3           4          5           6           7 
Difficulties with 
intellectual property 
rights (To keep the 
market advantages in 
longer term after the 
approval of the 
health claims.) 
 
    1          2           3           4          5           6           7 
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Barriers/difficulties  Influence 
 
Not 
relevan
t 
No 
influenc
e 
Very 
slight 
influenc
e 
Slightly 
Influenc
e 
Moderat
e 
influenc
e 
Strong 
influenc
e 
Very 
strong 
influenc
e 
Extremel
y strong 
influence 
Inappropriate 
protection for use of 
successful health 
claims (to ensure 
appropriate return 
on investment) 
 
    1          2           3           4          5           6           7 
Other, please specify:   
      1          2           3           4          5           6           7 
      1          2           3           4          5           6           7 
      1          2           3           4          5           6           7 
Barriers/difficulti
es 
 Influence 
 
Not 
relevant No 
influence 
Very 
slight 
influenc
e 
Slightly 
Influenc
e 
Moderat
e 
influence 
Strong 
influenc
e 
Very 
strong 
influenc
e 
Extreme
ly strong 
influenc
e 
TECHNICAL AND 
TECHNOLOGICAL 
  
Lack of 
communication 
with the national 
and/or EU 
authorities 
 
    1          2           3           4          5           6           7 
Lack of 
guidelines/suppor
ting documents 
 
    1          2           3           4          5           6           7 
Lack of specialised 
human resource 
 
    1          2           3           4          5           6           7 
Lack of 
communication 
within the 
company 
 
    1          2           3           4          5           6           7 
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Barriers/difficulties  Influence 
 
Not 
relevan
t 
No 
influenc
e 
Very 
slight 
influenc
e 
Slightly 
Influenc
e 
Moderat
e 
influenc
e 
Strong 
influenc
e 
Very 
strong 
influenc
e 
Extremel
y strong 
influence 
Lack of knowledge 
(how best to 
conduct RCT, 
statistics) 
 
    1          2           3           4          5           6           7 
Lack of specific 
technology 
 
    1          2           3           4          5           6           7 
Lack of applicable 
technology 
 
    1          2           3           4          5           6           7 
Lack of tools 
(specific material 
to evaluated 
results) 
 
    1          2           3           4          5           6           7 
Difficulties in food 
characterisation 
(e.g. polyphenols) 
 
    1          2           3           4          5           6           7 
Other, please 
specify: 
 
 
      1          2           3           4          5           6           7 
      1          2           3           4          5           6           7 
      1          2           3           4          5           6           7 
Barriers/difficultie
s 
 Influence 
 
Not 
relevant No 
influence 
Very 
slight 
influenc
e 
Slightly 
Influenc
e 
Moderat
e 
influence 
Strong 
influenc
e 
Very 
strong 
influenc
e 
Extremely 
strong 
influence 
ECONOMIC   
Lack of market 
information 
 
    1          2           3           4          5           6           7 
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Barriers/difficulties  Influence 
 
Not 
relevan
t 
No 
influenc
e 
Very 
slight 
influenc
e 
Slightly 
Influenc
e 
Moderat
e 
influenc
e 
Strong 
influenc
e 
Very 
strong 
influenc
e 
Extremel
y strong 
influence 
Lack of connection 
with the research 
and development 
area 
 
    1          2           3           4          5           6           7 
Lack of internal 
resources 
 
    1          2           3           4          5           6           7 
Length of the 
process of 
authorization 
 
    1          2           3           4          5           6           7 
Return of 
investment not 
guaranteed 
 
    1          2           3           4          5           6           7 
Unfair commercial 
practices 
 
    1          2           3           4          5           6           7 
Rising input costs      1          2           3           4          5           6           7 
Cost of conducting 
human 
intervention 
studies if no 
relevant data are 
available 
 
    1          2           3           4          5           6           7 
Cost for preparing 
the health claim 
dossier 
 
    1          2           3           4          5           6           7 
Lack of 
enforcement of 
health claim 
regulation by 
member states 
 
    1          2           3           4          5           6           7 
Other, please 
specify: 
 
 
      1          2           3           4          5           6           7 
      1          2           3           4          5           6           7 
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Barriers/difficulties  Influence 
 
Not 
relevan
t 
No 
influenc
e 
Very 
slight 
influenc
e 
Slightly 
Influenc
e 
Moderat
e 
influenc
e 
Strong 
influenc
e 
Very 
strong 
influenc
e 
Extremel
y strong 
influence 
      1          2           3           4          5           6           7 
3.14 Where do you need additional support in the process of preparation of a health claims dossier? 
(Please tick more than one box if applicable!) 
 
  Collection of market information 
  Collection of information about the requirements and behaviour of the consumers 
  Collection of scientific data/information 
  Making connection with the research and development area 
  Knowledge of the process for developing a health claim dossier 
  Collection of information about the prohibited and accepted health claim dossiers 
  Purchasing the appropriate compounds/raw materials 
  Establishing the relationship between the food/constituent and the claimed effect 
  Finding the appropriate active substance 
  Extracting the appropriate active substance 
  Stabilising the appropriate active substance 
  Integrating the appropriate active substance in the food matrix 
  Carrying out proper shelf-life test 
  Carrying out human studies 
  Carrying out other studies (e.g. animal) 
  Calculation of the nutrition profile of the product 
  Labelling 
  Set up health claim dossier 
  Communication with the national and/or EU authorities 
  Preparation the whole health claim dossier 
  Other, please specify________________________________ 
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3.15 What types of knowledge/information transfer activities are preferred by your company? (Please tick 
more than one box if applicable!) 
  Personnel consultations with experts 
  Exhibitions and workshops about the health claim products and processes 
  Training course about the process of the submission/authorisation of health claims 
  Guidelines for carrying out the different tests and studies 
  Platform for dossier pre-assessment 
  Consultancy company (preparation and complete of the health claim dossier) 
  Professional website focusing on nutrition and claims 
  E-net discussion forum 
 Other (please, specify it): __________________________ 
 
IF YOUR COMPANY DOES NOT SUBMIT HEALTH CLAIMS DOSSIERS: 
3.16 Are there any reasons why you do not use health claims within your company? (Please tick more than 
one box if applicable!) 
  We are not interested; 
  We do not trust in the feasibility of such project’s results; 
  We do not believe there is an appropriate return on investment; 
  We do not have enough information/knowledge; 
  We do not have experience and the development is too much risk for us; 
  We are aware of the importance of health claims, but we do not have adequate resources/facilities to 
carry out the submission process within the company; 
  We do not have qualified persons for the related analyses; 
  We do not have the financial resources to submit a health claims dossier; 
  We set up health claim submission process in the past but it was a failure; 
  A dossier provides short term market advantages and but with excessive efforts in the substantiation. 
The difficulty is that the accepted health claim cannot be used by the competitors. (intellectual property rights).  
 (Please describe which difficulties you have met) _____________________________________________ 
  Other reasons (please describe) _______________________________________________________ 
